Anthony D. Sung

Anthony D. Sung

Auto-generated profile, based on publicly available information

Anthony D. Sung

University of Kansas Medical Center

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in Science
Verified
Journal Article
Closed access
HGHao Guo
Hao Guo
WCWei-Chun Chou
Wei-Chun Chou
YLYunjia Lai
Yunjia Lai
KLKaixin Liang
Kaixin Liang
JTJason W. Tam
Jason W. Tam
JTJenny P. Y. Ting
Jenny P. Y. Ting
Radioprotective bacteria: A common symptom of radiation treatment for cancer is gastrointestinal disruption. The damage caused can become so severe and debilitating that it interrupts treatment. Guo et al. noticed that mice surviving experimental radiation exposure had distinctive taxonomic representation in their gut microbiota. A similar correlation was also observed in a small group of human subjects. Further experiments in mice revealed that some strains of bacteria produced high levels of short-chain fatty acids, which seemed to be dampening inflammatory responses and alleviating the damage caused by reactive oxygen species released by the radiation. A metabolomics analysis also implicated a role for tryptophan metabolic pathways in radiation survivorship. Science , this issue p. eaay9097

19 December 2012 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
ASAnthony D. Sung
Anthony D. Sung
NCNelson J. Chao
Nelson J. Chao
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (AHSCT) associated with significant morbidity and mortality. This review focuses on the pathophysiology, clinical features, prevention, and treatment of acute GVHD. Specifically, we explain how new discoveries in immunology have expanded our understanding of GVHD, in which tissue damage from chemotherapy or radiation results in cytokine release, which activates T cells, resulting in proliferation and differentiation, trafficking to target organs, and tissue destruction and inflammation. Insights into the mechanisms of this disease relate directly to the development of preventive strategies and therapies, such as immunosuppression, T-cell depletion, calcineurin inhibitors, CCR5 antagonists, gut decontamination, extracorporeal photopheresis, and more. We also discuss how GVHD affects the gut, liver, and skin, as well as diagnosis, grading, and scoring. We end by examining future directions of treatment, including new immunomodulators and biomarkers. Understanding the immunobiology of GVHD and developing effective preventions and treatments are critical to the continuing success of AHSCT.

1 July 2018 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
TATessa M. Andermann
Tessa M. Andermann
JPJonathan U. Peled
Jonathan U. Peled
CHChristine Ho
Christine Ho
PRPavan Reddy
Pavan Reddy
MRMarcie Riches
Marcie Riches
ABAmi S. Bhatt
Ami S. Bhatt

25 May 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
HAHana Andrlová
Hana Andrlová
OMOriana Miltiadous
Oriana Miltiadous
AKAnastasia I. Kousa
Anastasia I. Kousa
ADAnqi Dai
Anqi Dai
SDSusan DeWolf
Susan DeWolf
KMKate A. Markey
Kate A. Markey
Microbial diversity is associated with improved outcomes in recipients of allogeneic hematopoietic cell transplantation (allo-HCT), but the mechanism underlying this observation is unclear. In a cohort of 174 patients who underwent allo-HCT, we demonstrate that a diverse intestinal microbiome early after allo-HCT is associated with an increased number of innate-like mucosal-associated invariant T (MAIT) cells, which are in turn associated with improved overall survival and less acute graft-versus-host disease (aGVHD). Immune profiling of conventional and unconventional immune cell subsets revealed that the prevalence of Vδ2 cells, the major circulating subpopulation of γδ T cells, closely correlated with the frequency of MAIT cells and was associated with less aGVHD. Analysis of these populations using both single-cell transcriptomics and flow cytometry suggested a shift toward activated phenotypes and a gain of cytotoxic and effector functions after transplantation. A diverse intestinal microbiome with the capacity to produce activating ligands for MAIT and Vδ2 cells appeared to be necessary for the maintenance of these populations after allo-HCT. These data suggest an immunological link between intestinal microbial diversity, microbe-derived ligands, and maintenance of unconventional T cells.

2 November 2022 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
RSRoni Shouval
Roni Shouval
NWNicholas R. Waters
Nicholas R. Waters
AGAntonio Gomes
Antonio Gomes
CBCorrado Zuanelli Brambilla
Corrado Zuanelli Brambilla
TFTeng Fei
Teng Fei
MBMarcel R.M. van Den Brink
Marcel R.M. van Den Brink
Purpose: The gut microbiota is subject to multiple insults in allogeneic hematopoietic cell transplantation (allo-HCT) recipients. We hypothesized that preparative conditioning regimens contribute to microbiota perturbation in allo-HCT. Experimental Design: This was a retrospective study that evaluated the relationship between conditioning regimens exposure in 1,188 allo-HCT recipients and the gut microbiome. Stool samples collected from 20 days before transplantation up to 30 days after were profiled using 16S rRNA sequencing. Microbiota injury was quantified by changes in α-diversity. Results: We identified distinct patterns of microbiota injury that varied by conditioning regimen. Diversity loss was graded into three levels of conditioning-associated microbiota injury (CMBI) in a multivariable model that included antibiotic exposures. High-intensity regimens, such as total body irradiation (TBI)–thiotepa-cyclophosphamide, were associated with the greatest injury (CMBI III). In contrast, the nonmyeloablative regimen fludarabine–cyclophosphamide with low-dose TBI (Flu/Cy/TBI200) had a low-grade injury (CMBI I). The risk of acute GVHD correlated with CMBI degree. Pretransplant microbial compositions were best preserved with Flu/Cy/TBI200, whereas other regimens were associated with loss of commensal bacteria and expansion of Enterococcus. Conclusions: Our findings support an interaction between conditioning at the regimen level and the extent of microbiota injury.

1 October 2021 in JCO Oncology Practice
Verified
Journal Article
Open access
ATAaron M. Tarnasky
Aaron M. Tarnasky
GTGeorge N. Tran
George N. Tran
JNJonathan Nicolla
Jonathan Nicolla
FFFred A. P. Friedman
Fred A. P. Friedman
SWSteven Wolf
Steven Wolf
SZS. Yousuf Zafar
S. Yousuf Zafar
PURPOSE:Insured patients with cancer face high treatment-related, out-of-pocket (OOP) costs and often cannot access financial assistance. We conducted a randomized, controlled trial of Bridge, a pa...